{
    "id": 6691,
    "fullName": "KEAP1 inact mut",
    "impact": "unknown",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "KEAP1 inact mut indicates that this variant results in a loss of function of the Keap1 protein. However, the specific amino acid change has not been identified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 9817,
        "geneSymbol": "KEAP1",
        "terms": [
            "KEAP1",
            "INrf2",
            "KLHL19"
        ]
    },
    "variant": "inact mut",
    "createDate": "05/28/2015",
    "updateDate": "10/08/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2257,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, gallbladder cancer cells harboring KEAP inactivating mutations had increased NRF2 activation and demonstrated resistance to Adrucil (fluorouracil) in culture (PMID: 18692501).",
            "molecularProfile": {
                "id": 6544,
                "profileName": "KEAP1 inact mut"
            },
            "therapy": {
                "id": 1715,
                "therapyName": "Fluorouracil",
                "synonyms": null
            },
            "indication": {
                "id": 3121,
                "name": "gallbladder cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 2843,
                    "pubMedId": 18692501,
                    "title": "Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18692501"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 6544,
            "profileName": "KEAP1 inact mut",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}